Title:
ｅｘ ｖｉｖｏでの上皮細胞の増殖
Document Type and Number:
Japanese Patent JP6869231
Kind Code:
B2
Abstract:
The present invention relates to a defined xeno-free cell culture composition comprising i) one or more transforming growth factor beta (TGF-beta) inhibitors, and ii) one or more defined xeno-free serum replacement components.
Inventors:
Jean, Chen Kang
Application Number:
JP2018512900A
Publication Date:
May 12, 2021
Filing Date:
September 07, 2016
Export Citation:
Assignee:
Propagenics Incorporated
International Classes:
C12N5/071
Domestic Patent References:
| JP2008538180A | ||||
| JP2014502151A | ||||
| JP63304978A |
Foreign References:
| WO2007002900A1 | ||||
| WO2013061608A1 | ||||
| US20140335616 |
Other References:
フナコシ株式会社, 動物由来成分フリーの組換え体ヒト血清アルブミン,[online], 2011,
Cancer Sci.,2005年,vol. 96, no. 11,p. 791-800
The American Journal of Pathology,2013年,vol. 183, no. 6,p. 1862-1870
Cancer Sci.,2005年,vol. 96, no. 11,p. 791-800
The American Journal of Pathology,2013年,vol. 183, no. 6,p. 1862-1870
Attorney, Agent or Firm:
Hidesaku Yamamoto
Natsuki Morishita
Takatoshi Iida
Daisuke Ishikawa
Kensaku Yamamoto
Natsuki Morishita
Takatoshi Iida
Daisuke Ishikawa
Kensaku Yamamoto